Levobunolol
| CAS No. | 47141-42-4 |
|---|---|
| MDL No. | N/A |
| MF | C17H25NO3 |
| MW | 291.40 |
| InChI Key | IXHBTMCLRNMKHZ-LBPRGKRZSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Levobunolol is a cyclic ketone, specifically 3,4-dihydronaphthalen-1-one substituted at position 5 with a 3-(tert-butylamino)-2-hydroxypropoxy group (the S-enantiomer). It is a non-selective beta-adrenergic antagonist, used as its hydrochloride salt in the treatment of glaucoma. It functions as an antiglaucoma drug and beta-adrenergic antagonist. It is classified as a propanolamine, cyclic ketone, and aromatic ether. It is the conjugate base of levobunolol(1+), derived from a tetralin hydride.
| CAS No. | 47141-42-4 |
|---|---|
| Product Name | Levobunolol |
Biological Targets
ADRB1·ADRB2
Associated Conditions
glaucoma
* The information provided here is compiled from public sources and is for reference only.
